A rating of 90 puts ImmunoGen, Inc. (IMGN) near the top of the Healthcare sector according to InvestorsObserver.
ImmunoGen, Inc.'s score of 90 means that it ranks higher than 90% of stocks in the sector. In addition, its overall score of 74 ranks it higher than 74% of all stocks.
IMGN has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on IMGN!
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds.
The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With ImmunoGen, Inc. Stock Today?
ImmunoGen, Inc. (IMGN) stock is trading at $6.87 as of 10:03 AM on Thursday, Dec 2, an increase of $0.10, or 1.48% from the previous closing price of $6.77. The stock has traded between $6.85 and $7.09 so far today. Volume today is light. So far 3,571,624 shares have traded compared to average volume of 5,009,532 shares.
Click Here to get the full Stock Report for ImmunoGen, Inc. stock.